Skip to main content

Clinic Technology Beyond the EMR

Digital Drug References and Interaction Checkers for Doctors

How doctors in India use drug reference apps and interaction checkers safely: choosing sources, Indian brands, FDC bans, alert fatigue and reporting reactions.

Bractis clinic guides · Updated · 4 min read

Short answer

Digital drug references and interaction checkers help doctors confirm doses, contraindications, interactions and Indian brand names at the point of prescribing. Use sources with clear editorial review and update dates, check that Indian brands and fixed-dose combinations map to the right ingredients, be aware of drugs and combinations banned by CDSCO, treat interaction alerts as prompts for judgement rather than orders, avoid entering identifiable patient data into consumer apps, and report suspected adverse reactions to the Pharmacovigilance Programme of India.

Why digital references matter

Indian doctors prescribe from thousands of brands, many of them fixed-dose combinations, and patients often take medicines from several doctors and chemists at once. A quick check of dose, renal adjustment, pregnancy safety or interactions takes seconds on a phone or computer and can prevent harm. Printed references go out of date; digital ones can be updated, but only if the publisher actually does so.

This guide is general information. Clinical decisions remain the prescribing doctor's responsibility.

Types of references

On a narrow screen, scroll the table sideways to see every column.

TypeUseWatch for
National reference, such as the National Formulary of IndiaStandard doses, cautions, interactions for medicines used in IndiaUpdate frequency; check the edition
Drug brand databasesFind ingredients and strengths behind Indian brandsAccuracy of brand-to-ingredient mapping
Interaction checkersCheck combinations of several drugsOver-alerting and missing Indian FDCs
Paediatric dosing toolsWeight-based dosesUnits, formulations and maximum doses
Renal and hepatic dosing referencesDose adjustmentUse current kidney function, not old values
Pregnancy and lactation referencesSafety of medicinesEvidence changes; check dates
Prescribing software with built-in checksAlerts while prescribingWhich reference powers it, and when it was updated

Choosing a source

  • Who writes and reviews the content, and are their names and qualifications shown?
  • When was each entry last updated?
  • Does it cover Indian brands and fixed-dose combinations?
  • Does it show the reasoning and evidence behind an alert, not only a warning?
  • Is it free of advertising for specific brands?
  • Does it work offline, for clinics with weak internet?

Be cautious with apps funded mainly by pharmaceutical advertising, which may favour particular brands.

Indian brands and fixed-dose combinations

Many interaction checkers are built for international markets and may not recognise Indian brand names or combinations. Always check that the tool maps the brand to the right ingredients and strengths. CDSCO has banned many fixed-dose combinations over the years; check the current list before prescribing an unfamiliar combination. Prescribing by generic name, as professional conduct rules encourage, also makes interaction checks easier.

Alert fatigue

Interaction checkers often show many low-importance alerts. Doctors then learn to click past all of them, including the dangerous ones. Look for tools that grade severity and let you focus on major interactions. When an alert appears, think about the patient in front of you: dose, duration, kidney and liver function, age and other conditions. Document your decision when you go ahead despite a major alert.

Patient privacy

Many consumer drug apps collect data about searches and users. Avoid entering patient names, phone numbers or other identifying details into apps that are not part of the clinic's records system. Under the DPDP Act, patient data should be shared only for a clear purpose with appropriate safeguards. A drug name and dose alone, without patient identifiers, is usually enough for a reference check.

AI tools

AI assistants can summarise drug information quickly, but they can also produce confident errors. Use them, if at all, as a starting point and confirm doses and interactions in a reliable reference. Never paste identifiable patient details into general AI tools.

Reporting adverse reactions

When you suspect an adverse drug reaction, report it to the Pharmacovigilance Programme of India, run by the Indian Pharmacopoeia Commission. Reports from practising doctors help detect safety problems with medicines used in India. Record the reaction in the patient's record and tell the patient.

Building references into the workflow

The most useful reference is the one you will actually open during a busy OPD. Keep one or two trusted sources bookmarked on each consultation computer and phone. Agree as a clinic which references to use, so doctors and staff give consistent advice. A shared clinic formulary listing preferred medicines, doses and common interactions can save time for common prescriptions.

A worked example

A general practitioner seeing many elderly patients found that several were taking medicines prescribed by different specialists, some with overlapping ingredients hidden behind brand names. He began asking patients to bring all their medicine strips, checked brand ingredients in a drug database, and ran the combination through an interaction checker that grades severity. In one month he found three patients taking two brands of the same painkiller and one patient on a combination with a major bleeding risk. He documented each change and wrote to the other doctors.

Special groups to check every time

Some patients need a reference check for almost every prescription. Children need weight-based doses and suitable formulations. Older adults often take five or more medicines and are more sensitive to sedatives, anticholinergics and drugs that affect the kidneys. Pregnant and breastfeeding women need safety checks that change as evidence grows. Patients with kidney or liver disease need dose adjustment based on current results, not old reports. Building a habit of checking for these groups catches most serious errors, and a quick note in the record shows that the check was done.

Common mistakes

  • Trusting an international checker that does not know Indian brands.
  • Clicking past every alert.
  • Entering patient identifiers into consumer apps.
  • Using outdated references.
  • Not reporting adverse reactions.

Where Bractis fits

Bractis supports safer prescribing with clear, legible prescriptions and the visit history in one place. For built-in drug references and interaction checks, ask the team what is supported today and test it with your common prescriptions.

Frequently asked questions

Which drug reference should Indian doctors use?

Use sources with clear editorial review and recent updates that cover Indian medicines, such as the National Formulary of India, alongside trusted clinical references.

Are free drug apps reliable?

Some are, but check who writes the content, when it was updated and whether advertising influences it.

Do interaction checkers know Indian brands?

Not always. Check that the brand maps to the right ingredients.

How do I report an adverse drug reaction?

Report it to the Pharmacovigilance Programme of India through its reporting form or app.

Run this in your own clinic

Bractis is clinic management software built for Indian OPDs: appointments, patient records, prescriptions, billing and follow-up in one place. You can try it in your own clinic before you decide.

Sources and review

Written by the Bractis editorial team for doctors and clinic owners in India. Rules, fees and prices change: check the linked primary sources before acting, and ask your CA or lawyer about your own case.